Blood Test With Potential to Detect Stage One Cancer: Soricimed Biopharma Inc. Announces Initiation of Cancer Diagnostic Study - press release

Blood Test With Potential to Detect Stage One Cancer: Soricimed Biopharma Inc. Announces Initiation of Cancer Diagnostic Study

"Half the battle with cancer is being able to detect it early enough to save lives", stated Elisabeth Ross, Chief Executive Officer, Ovarian Cancer Canada. "In the case of ovarian cancer, there are no early symptoms and currently no screening tests available so it's not usually detected until Stage Three or Four........"



" Soricimed Biopharma Inc., a private clinical stage company developing novel cancer therapeutics and diagnostics, announced that a pre-regulatory study of their blood test for early detection of cancer has commenced.

Soricimed developed their blood test to detect the presence of TRPV6 messenger RNA, a biomarker identified as being present in many epithelially derived cancers. The test has been shown to detect a host of cancers, including ovarian, breast and prostate, at their earliest stages......